Vivani Medical, INC. (VANI) — 10-Q Filings

10-Q Filings (5)

• Vivani's Losses Widen Amid Increased R&D for GLP-1 Implants — Nov 13, 2025 Risk: high
  Vivani Medical, Inc. (VANI) reported a net loss of $6.53 million for the three months ended September 30, 2025, an increase from $6.04 million in the same perio
• Vivani's Losses Widen Amid R&D Push; Cash Dwindles — Aug 13, 2025 Risk: high
  Vivani Medical, Inc. (VANI) reported a net loss of $7.144 million for the three months ended June 30, 2025, an increase from $5.356 million in the same period o
• Vivani Medical Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
  Vivani Medical, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Second Sight Medical Products Inc., is incorporated
• Vivani Medical Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  Vivani Medical, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and provided updates on its business operations.
• Vivani Medical, Inc. Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: low
  Vivani Medical, Inc. (VANI) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Vivani Medical, Inc. filed a 10-Q report for the period ending March 3

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX